9/12/2022 9:39:47 AM
Perrigo :FDA Panel Scheduled Meeting On Nov 18 To Review Application For Opill Daily Oral Contraceptive For OTC Use
8/9/2022 6:32:19 AM
Perrigo Q2 Loss Per Share $0.48; Adj EPS $0.43
8/2/2022 9:25:04 AM
Perrigo Declares Quarterly Dividend Of $0.26/shr; Payable September 20/record September 2
8/2/2022 9:23:06 AM
Perrigo Company plc (PRGO) Declares Quarterly Dividend of $ 0.26, Record Date 9/2/2022
7/11/2022 6:02:17 AM
Perrigo's HRA Pharma Submits Application To FDA For OTC Birth Control Pill In The United States
5/11/2022 6:37:47 AM
Perrigo Company plc (PRGO) Has Raised Its FY22 EPS Estimate To 2.30 - 2.40 From 2.10 - 2.30
5/11/2022 6:35:25 AM
Perrigo Q1 Reported Loss Per Share $0.02; Adj EPS $0.33
5/11/2022 6:24:39 AM
Perrigo Names Eduardo Bezerra EVP And CFO, Succeeding Ray Silcock
5/5/2022 8:39:31 AM
Perrigo Company plc (PRGO) Declares Quarterly Dividend of $ 0.26, Record Date 6/3/2022
5/5/2022 8:39:05 AM
Perrigo Co. Declares Quarterly Dividend Of $0.26, Payable June 21, Record June 3
5/2/2022 7:31:40 AM
Perrigo Completes Acquisition Of Héra SAS For EUR 1.8 Bln
3/28/2022 7:34:19 AM
Perrigo Launches Syndication Of New Senior Secured Credit Facilities